Search results for: NICE
Filter search results
Spotlight on OHE: Competition in the NHS, HESG, Publications
17 July 2014
…costs of implementing NICE decisions in NHS Wales. A paper co-authored by Yan Feng, Michele Pistollato, Anita Charlesworth, Nance Devlin, Carol Propper and Jon Sussex that assesses the relationship between market…
OHE at the Health Economists’ Study Group (HESG) Meeting, Manchester 2016
4 January 2016
…research programme. OHE work being discussed is detailed below. Authors: Koonal Shah, Aki Tsuchiya and Allan Wailoo. Summary: The National Institute for Health and Care Excellence (NICE) has, since…
Alastair Fischer appointed as Senior Visiting Fellow at OHE
30 January 2017
…effectiveness of attempts to reduce substance misuse, along with co-authors from University of Liverpool and NICE Public Health Guidelines. The evaluation and kite-marking of health apps by NICE or elsewhere…
How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper
18 July 2018
…involved in clinical trials for those novel drugs approvals issued in 2015 are collected from ClinicalTrials.gov. Data to estimate differences in revenues are collected from all appraisals conducted by NICE…
Establishing a Reasonable Price for an Orphan Drug
11 September 2020
…target patient populations of both orphan and non-orphan drugs from the Scottish Medicines Consortium (SMC) and National Institute for Health and Care Excellence (NICE). Both differences in research and development…
Rare Disease Day 2022
28 February 2022
…discussed in an OHE Consulting Report, particularly in the context of NICE’s appraisal of rare and ultra-rare conditions. We also considered to what extent standard appraisal processes are appropriate for…
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
1 March 2019
…between health outcomes and health expenditures in England. Results suggest that setting a cost-effectiveness criterion for NICE may not be capable of being synthesised using scientific methods alone, but involve…
Dr. Jacoline Bouvy
19 March 2024
…produced by NICE’s Technology Appraisals and Highly Specialised Technologies work programmes. Prior to joining NICE, Jacoline worked at the European Medicines Agency as a National Expert in the Pharmacovigilance Department….
OHE’s submission for the DHSC’s next 10 years of planning
9 December 2024
…that can boost user confidence and uptake. Enabler: There needs to be flexibility in value assessments of digital health technologies (DHT) similar to the NICE 2022 guidance of different appraisal…